Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
揭示內情：通過分析師的洞察力探索萊斯康製藥
A comprehensive examination of how financial experts perceive Lexicon Pharmaceuticals is...During the last three months, 8 analysts shared their evaluations of Lexicon Pharmaceuticals (NASDAQ:LXRX), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，8位分析師分享了對萊斯康製藥（納斯達克股票代碼：LXRX）的評估，展現出從看好到看淡不同的展望。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.0, a high estimate of $10.00, and a low estimate of $10.00. No alteration is observed as the current average remains at the previous average price target.
分析師們分析的12個月價位目標提供了見解，平均目標爲$10.0，最高估值爲$10.00，最低估值爲$10.00。當前平均仍保持在先前的平均價位目標，未觀察到任何變化。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A comprehensive examination of how financial experts perceive Lexicon Pharmaceuticals is...
最近的分析師行動揭示了...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間